Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)

GlaxoSmithKline41 enrolled

Overview

This post-marketing surveillance (PMS) study is designed to investigate the efficacy and safety of azathioprine tablets in Japanese subjects whom liver transplantation is performed.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Liver Diseases

Interventions

AzathioprineDRUG

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects who undergo liver transplantation and azathioprine tablet was administered Exclusion Criteria: As this is PMS study, there are no exclusion criteria but contraindications are as follows. * Subjects with hypersensitivity to the ingredients of azathioprine tablet * Subjects who is pregnant or might be pregnant * Subjects whose white count is lower than 3000/cubic millimeter

Outcomes

Primary Outcomes

The number of incidence of adverse events related to azathioprine tablets and serious adverse events

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.